| Samuel D Swisher-mcclure, MD | |
|
18947 John J Williams Hwy Unit 101, Rehoboth Beach, DE 19971-4480 | |
| (302) 645-3775 | |
| (302) 645-3774 |
| Full Name | Samuel D Swisher-mcclure |
|---|---|
| Gender | Male |
| Speciality | Radiation Oncology |
| Experience | 17 Years |
| Location | 18947 John J Williams Hwy Unit 101, Rehoboth Beach, Delaware |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1669675880 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Beebe Medical Center | Lewes, DE | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Delmarva Radiation Services, Pa | 6507801750 | 4 |
News Archive
These stem cells can reproduce and be converted into various types of brain cells. To date, only reprogramming in brain cells that were already fully developed or which had only a limited ability to divide was possible. The new reprogramming method presented by the Bonn scientists and submitted for publication in July 2011 now enables derivation of brain stem cells that are still immature and able to undergo practically unlimited division to be extracted from conventional body cells.
For more than five years, urine and cerebral-spinal fluid samples from patients with Parkinson's disease have been locked in freezers in the NINDS National Repository, stored with the expectation they might someday help unravel the still-hidden course of this slow-acting neurodegenerative disease.
Kitov Pharmaceuticals, an innovative biopharmaceutical company focused on late-stage drug development, announced today that the Phase III, double-blind, placebo-controlled clinical trial for its leading drug candidate, KIT-302, successfully met the primary efficacy endpoint of the trial protocol as approved by the U.S. Food & Drug Administration (FDA).
Today, the International and American Associations for Dental Research (IADR/AADR) published a paper titled "-catenin is Required in Odontoblasts for Tooth Root Formation." The paper, written by lead authors Tak-Heun Kim and Cheol-Hyeon Bae, Chonbuk National University Korea School of Dentistry, Laboratory for Craniofacial Biology, is published in the IADR/AADR Journal of Dental Research.
Researchers funded by the National Institute of Mental Health (NIMH), have found that requests from patients for medications have a "profound effect" on physicians prescribing for major depression and adjustment disorder. These findings indicate that direct-to-consumer (DTC) marketing of prescription medications for depression may exert significant influence on treatment decisions.
› Verified 5 days ago
| Entity Name | Delmarva Radiation Services, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992740906 PECOS PAC ID: 6507801750 Enrollment ID: O20050628000401 |
News Archive
These stem cells can reproduce and be converted into various types of brain cells. To date, only reprogramming in brain cells that were already fully developed or which had only a limited ability to divide was possible. The new reprogramming method presented by the Bonn scientists and submitted for publication in July 2011 now enables derivation of brain stem cells that are still immature and able to undergo practically unlimited division to be extracted from conventional body cells.
For more than five years, urine and cerebral-spinal fluid samples from patients with Parkinson's disease have been locked in freezers in the NINDS National Repository, stored with the expectation they might someday help unravel the still-hidden course of this slow-acting neurodegenerative disease.
Kitov Pharmaceuticals, an innovative biopharmaceutical company focused on late-stage drug development, announced today that the Phase III, double-blind, placebo-controlled clinical trial for its leading drug candidate, KIT-302, successfully met the primary efficacy endpoint of the trial protocol as approved by the U.S. Food & Drug Administration (FDA).
Today, the International and American Associations for Dental Research (IADR/AADR) published a paper titled "-catenin is Required in Odontoblasts for Tooth Root Formation." The paper, written by lead authors Tak-Heun Kim and Cheol-Hyeon Bae, Chonbuk National University Korea School of Dentistry, Laboratory for Craniofacial Biology, is published in the IADR/AADR Journal of Dental Research.
Researchers funded by the National Institute of Mental Health (NIMH), have found that requests from patients for medications have a "profound effect" on physicians prescribing for major depression and adjustment disorder. These findings indicate that direct-to-consumer (DTC) marketing of prescription medications for depression may exert significant influence on treatment decisions.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Samuel D Swisher-mcclure, MD Po Box 497, Lewes, DE 19958-0497 Ph: (302) 645-3775 | Samuel D Swisher-mcclure, MD 18947 John J Williams Hwy Unit 101, Rehoboth Beach, DE 19971-4480 Ph: (302) 645-3775 |
News Archive
These stem cells can reproduce and be converted into various types of brain cells. To date, only reprogramming in brain cells that were already fully developed or which had only a limited ability to divide was possible. The new reprogramming method presented by the Bonn scientists and submitted for publication in July 2011 now enables derivation of brain stem cells that are still immature and able to undergo practically unlimited division to be extracted from conventional body cells.
For more than five years, urine and cerebral-spinal fluid samples from patients with Parkinson's disease have been locked in freezers in the NINDS National Repository, stored with the expectation they might someday help unravel the still-hidden course of this slow-acting neurodegenerative disease.
Kitov Pharmaceuticals, an innovative biopharmaceutical company focused on late-stage drug development, announced today that the Phase III, double-blind, placebo-controlled clinical trial for its leading drug candidate, KIT-302, successfully met the primary efficacy endpoint of the trial protocol as approved by the U.S. Food & Drug Administration (FDA).
Today, the International and American Associations for Dental Research (IADR/AADR) published a paper titled "-catenin is Required in Odontoblasts for Tooth Root Formation." The paper, written by lead authors Tak-Heun Kim and Cheol-Hyeon Bae, Chonbuk National University Korea School of Dentistry, Laboratory for Craniofacial Biology, is published in the IADR/AADR Journal of Dental Research.
Researchers funded by the National Institute of Mental Health (NIMH), have found that requests from patients for medications have a "profound effect" on physicians prescribing for major depression and adjustment disorder. These findings indicate that direct-to-consumer (DTC) marketing of prescription medications for depression may exert significant influence on treatment decisions.
› Verified 5 days ago
Dr. Owen C. Thomas, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 18947 John J Williams Hwy Unit 101, Rehoboth Beach, DE 19971 Phone: 302-645-3775 Fax: 302-645-3774 | |
Dr. Andrejs V Strauss, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 18947 John J Williams Hwy, Tunnell Cancer Center, Rehoboth Beach, DE 19971 Phone: 302-645-3775 Fax: 302-645-3774 | |
Dr. Jennifer Hung, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 18947 John J Williams Hwy Unit 101, Rehoboth Beach, DE 19971 Phone: 302-645-3775 Fax: 302-645-3774 | |
Dr. Brian J. Costleigh, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 18947 John J Williams Hwy, Tunnell Cancer Center, Rehoboth Beach, DE 19971 Phone: 302-645-3775 Fax: 302-645-3774 |